Rethinking
What's Possible
With Vaccines
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.
The Needle-Free Future
Vaxxas' HD-MAP technology uses a patch with thousands of vaccine-coated microprojections that is applied to the skin for a few seconds to efficiently deliver vaccine to the abundant immune cells immediately below the skin surface.
Empowered To Do More
Vaxxas' approach shifts the value paradigm of vaccines. Vaxxas' HD-MAP platform has been:
- Productized for commercial use
- Validated in human clinical studies
- Designed for manufacture at scale
Vaxxas In The News
Explore what's possible for you
with Careers at Vaxxas
The People And Partners Behind Vaxxas
Our Team
We have assembled a passionate and experienced team committed to rethinking what’s possible with vaccines.
Partners
We partner with world renowned organizations to maximize the impact of our technology for people globally.